Neuromodulation in Drug Resistant Epilepsy

Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor to the global burden of neurological disorders. Despite the advent of new AEDs, drug resistant-epilepsy continues to affect 30-40% of PWE. Once identified as having drug-resistant epilepsy, these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rincon, Natalia, Barr, Donald, Velez-Ruiz, Naymee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219496/
https://www.ncbi.nlm.nih.gov/pubmed/34221550
http://dx.doi.org/10.14336/AD.2021.0211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219496/
https://www.ncbi.nlm.nih.gov/pubmed/34221550
http://dx.doi.org/10.14336/AD.2021.0211

Ejemplares similares